Illumina launches research test for HRD
June 22, 2022 -- Illumina on Wednesday announced the launch of a next-generation sequencing (NGS)-based research-use-only test for homologous recombination deficiency that it has developed with Merck. Read More
Dxcover launches platform for early cancer detection
June 20, 2022 -- Dxcover said Monday that it is launching an infrared platform that enables faster sample analysis and improves on commercial attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy for the early detection of multiple cancers. Read More
Paige, Janssen collaborating on AI-based bladder cancer test
June 15, 2022 -- Paige on Wednesday announced a collaboration with Janssen Research & Development to evaluate the potential of a hematoxylin and eosin (H&E) and artificial intelligence (AI)-based biomarker test. Read More
Ibex Medical Analytics gets CE Mark for AI-based gastric test
June 15, 2022 -- Artificial intelligence (AI)-based cancer diagnostics developer Ibex Medical Analytics has received the CE Mark for its Galen Gastric test to detect various types of gastric cancer as well as cancer precursor Helicobacter pylori, neuroendocrine lesions, dysplasia, and adenoma. Read More
Thermo Fisher Scientific obtains CE Mark for NGS, Dx workflows
June 15, 2022 -- Thermo Fisher Scientific has received a CE-IVD Mark under the In Vitro Diagnostic Medical Devices Directive (IVDD) for its Ion Torrent Reporter Software Aneuploidy Dx Workflows for the detection of aneuploidies. Read More
Proscia raises $37M in Series C financing
June 14, 2022 -- Proscia on Tuesday announced it has raised $37 million in a Series C financing round to support the adoption of computational pathology products and scale its commercial operations. Read More
Flagship Biosciences announces study validating assay
June 14, 2022 -- Flagship Biosciences on Tuesday announced the publication of a paper describing the validation of its digital spatial biology assay, Tissue Insight (TI) 22C3 NSCLC, in Scientific Reports. Read More
FDA clears Scopio Labs hematology analysis platform
June 10, 2022 -- Medtech firm Scopio Labs announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its X100HT device with peripheral blood smear applications. Read More
PathAI to present AI pathology studies at London liver congress
June 9, 2022 -- Digital pathology firm PathAI announced it will participate in three presentations that describe its technologies at the International Liver Conference 2022 in London on June 22-26. Read More
Proscia nabs CE Mark under IVDR for digital pathology platform
June 8, 2022 -- Proscia announced it has obtained the CE Mark under IVDR, the new European in vitro diagnostic regulation, for use of its Concentriq Dx digital pathology platform in primary diagnosis. Read More